MedPath

Dexamethasone Intensol

Dexamethasone Tablets USP, Dexamethasone Oral Solution USP and Dexamethasone Oral Solution USP ™ (Concentrate)

Approved
Approval ID

a817ab46-54ec-4e3f-886b-04ce6ac1caf9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 6, 2016

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone Intensol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-5026
Application NumberANDA088252
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone Intensol
Product Specifications
Route of AdministrationORAL
Effective DateJuly 5, 2016
FDA Product Classification

INGREDIENTS (7)

DEXAMETHASONEActive
Quantity: 1 mg in 1 mL
Code: 7S5I7G3JQL
Classification: ACTIB
BENZOIC ACIDInactive
Code: 8SKN0B0MIM
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone Intensol - FDA Drug Approval Details